Close Menu
Home › LabCorp Q4 Revenues Rise 2 Percent, Diagnostic Revenues Dip

LabCorp Q4 Revenues Rise 2 Percent, Diagnostic Revenues Dip

Feb 07, 2019
|
staff reporter

NEW YORK (360Dx) – Laboratory Corporation of America reported today a 2 percent year-over-year revenue growth for the fourth quarter despite a 3 percent drop in diagnostic revenues.

Total revenues for the quarter ended Dec. 31, 2018 were $2.79 billion, up from $2.74 billion in the same quarter last year and matching the analysts' average estimate.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
30
Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Jul
31
Featured Webinar

Considerations and Impact of Implementing Targeted NGS in Myeloid Malignancies

Sponsored by
Thermo Fisher Scientific

This webinar will provide a first-hand look at how a molecular laboratory validated and implemented a targeted next-generation sequencing-based myeloid assay to expedite the assessment of myeloid malignancies and assist in the understanding of myeloid cancers.

What's Popular?

In Diagnostics

  1. Theradiag Posts 9 Percent Increase in H1 2019 Revenues

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.